April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Immune-Mediated Keratitis in Dogs Following Treatment with Topical Carbonic-Anhydrase Inhibitors
Author Affiliations & Notes
  • Billie Beckwith-Cohen
    Pathobiological Sciences, University of Wisconsin- Madison, Madison, WI
  • Ellison Bentley
    Surgical Sciences, University of Wisconsin- Madison, Madison, WI
  • David J Gasper
    Pathobiological Sciences, University of Wisconsin- Madison, Madison, WI
  • Richard R Dubielzig
    Pathobiological Sciences, University of Wisconsin- Madison, Madison, WI
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 6294. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Billie Beckwith-Cohen, Ellison Bentley, David J Gasper, Richard R Dubielzig; Immune-Mediated Keratitis in Dogs Following Treatment with Topical Carbonic-Anhydrase Inhibitors. Invest. Ophthalmol. Vis. Sci. 2014;55(13):6294.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To describe three clinical cases of immune-mediated keratitis (IMMK) following treatment with topical carbonic anhydrase inhibitors (CAI) and histopathology of two additional cases suspected of having this disease.

Methods: The complete medical records of three canine patients with IMMK following treatment with topical CAI were examined retrospectively. The past medical and ophthalmic histories were reviewed, and the time to onset of clinical signs after initiation of CAI therapy and their resolution following CAI discontinuation were recorded. Two cases with severe IMMK that received long-term CAI treatment which was not discontinued were examined histologically and stained with hematoxylin and eosin, as well as CD-20, CD-79a, CD-3 and IgG to phenotype the corneal inflammatory response.

Results: In all cases, the mean time to initial ocular signs following treatment with CAI was 233 days (range 7-672), and the mean time to severe signs was 355 days (range 133-679). Mean time to discontinuation of therapy in the three clinical cases was 284 days (range 161-433). Improvement was seen within 2-4 days of withdrawal, and signs resolved within 12-25 days. Mean follow-up time after discontinuation of CAI was 23 months (range 12-42). All five cases were refractory to anti-inflammatory medication. Histopathology showed a biphasic anterior stromal and intraepithelial lymphoplasmacytic inflammatory infiltrate and epithelial IgG deposition, most consistent with a hypersensitivity response.

Conclusions: Topical CAI associated keratitis in dogs is a non-steroid responsive immune-mediated disease that improves soon after CAI discontinuation. This is the first report of local side-effects following topical CAI in veterinary medicine.

Keywords: 443 carbonic anhydrase • 573 keratitis • 479 cornea: clinical science  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×